These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12205061)

  • 1. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
    J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; Bischofberger N; De Clercq E
    Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys.
    Cundy KC; Fishback JA; Shaw JP; Lee ML; Soike KF; Visor GC; Lee WA
    Pharm Res; 1994 Jun; 11(6):839-43. PubMed ID: 7937523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
    J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.
    Shaw JP; Louie MS; Krishnamurthy VV; Arimilli MN; Jones RJ; Bidgood AM; Lee WA; Cundy KC
    Drug Metab Dispos; 1997 Mar; 25(3):362-6. PubMed ID: 9172955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice.
    Balzarini J; Vahlenkamp T; Egberink H; Hartmann K; Witvrouw M; Pannecouque C; Casara P; Navé JF; De Clercq E
    Antimicrob Agents Chemother; 1997 Mar; 41(3):611-6. PubMed ID: 9056002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antitumor activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine in choriocarcinoma-bearing rats.
    Hatse S; Naesens L; Degrève B; Segers C; Vandeputte M; Waer M; De Clercq E; Balzarini J
    Int J Cancer; 1998 May; 76(4):595-600. PubMed ID: 9590139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
    Gangemi JD; Cozens RM; De Clercq E; Balzarini J; Hochkeppel HK
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1864-8. PubMed ID: 2482011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
    Naesens L; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):53-64. PubMed ID: 1776876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
    Starrett JE; Tortolani DR; Hitchcock MJ; Martin JC; Mansuri MM
    Antiviral Res; 1992 Sep; 19(3):267-73. PubMed ID: 1332606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
    Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
    FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
    J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.
    Egberink H; Borst M; Niphuis H; Balzarini J; Neu H; Schellekens H; De Clercq E; Horzinek M; Koolen M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3087-91. PubMed ID: 2158102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2).
    Annaert P; Kinget R; Naesens L; de Clercq E; Augustijns P
    Pharm Res; 1997 Apr; 14(4):492-6. PubMed ID: 9144737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayers.
    Annaert P; Gosselin G; Pompon A; Benzaria S; Valette G; Imbach JL; Naesens L; Hatse S; de Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Feb; 15(2):239-45. PubMed ID: 9523310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
    Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.
    Hatse S; Naesens L; De Clercq E; Balzarini J
    Biochem Pharmacol; 1998 Oct; 56(7):851-9. PubMed ID: 9774147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys.
    Cundy KC; Shaw JP; Lee WA
    Antimicrob Agents Chemother; 1994 Feb; 38(2):365-8. PubMed ID: 8192467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; De Clercq E
    Drug Metab Dispos; 1992; 20(5):747-52. PubMed ID: 1358582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.